Overview Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers Status: Completed Trial end date: 2012-09-01 Target enrollment: Participant gender: Summary This study in healthy male and female volunteers will investigate the safety and tolerability of three increasing oral doses of tafamidis Phase: Phase 1 Details Lead Sponsor: Pfizer